DrugPatentWatch Database Preview
ENLON-PLUS Drug Profile
» See Plans and Pricing
Which patents cover Enlon-plus, and what generic alternatives are available?
Enlon-plus is a drug marketed by Mylan Institutional and is included in two NDAs.
The generic ingredient in ENLON-PLUS is atropine sulfate; edrophonium chloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; edrophonium chloride profile page.
Summary for ENLON-PLUS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Bulk Api Vendors: | 19 |
| Patent Applications: | 2,593 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ENLON-PLUS at DailyMed |
US Patents and Regulatory Information for ENLON-PLUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019677-001 | Nov 6, 1991 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019678-001 | Nov 6, 1991 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ENLON-PLUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019677-001 | Nov 6, 1991 | Start Trial | Start Trial |
| Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019678-001 | Nov 6, 1991 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ENLON-PLUS
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 1200500 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
